4.7 Article

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium

期刊

CARDIOVASCULAR DIABETOLOGY
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12933-022-01513-9

关键词

Adrenomedullin; C-terminal-proendothelin-1; Endothelin-1; Epidemiology; Incident type 2 diabetes; Mendelian randomisation; Mid-regional-proadrenomedullin; Cohort study

资金

  1. Projekt DEAL
  2. European Union Seventh Framework Programme (FP7/2007-2013) [HEALTH-F2-2011-278913]
  3. EU [BMH4-CT98-3183, QLG2-CT-2002-01254]
  4. European Network for Genetic and Genomic Epidemiology (ENGAGE) (FP7) [HEALTH-F4-2007-201413]
  5. Consortium on Health and Ageing: Network of cohorts in Europe and the United States (CHANCES) (FP7), euCanSHare (Horizon 2020) [HEALTH-F3-2010-242244, 825903]
  6. Digital, Risk-based Screening for Atrial Fibrillation in the European Community project-European Union (AFFECT-EU) (Horizon 2020) [847770]
  7. Medical Research Council, London [G0601463, 80983]
  8. Helmholtz Zentrum Munchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)
  9. State of Bavaria
  10. Virtual Institute of Diabetes Research (Helmholtz Zentrum Munchen)
  11. Ludwig-MaximiliansUniversitat Munchen
  12. Helmholtz Zentrum Munchen
  13. German Diabetes Center (DDZ)
  14. Federal Ministry of Health (Berlin, Germany)
  15. Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany)
  16. German Research Foundation (DFG) [RA-45,913/3-1]
  17. Finnish Institute for Health and Welfare
  18. Academy of Finland
  19. Health and Social Care (HSC) Research and Development Office of the Northern Ireland Public Health Agency
  20. UK Prevention Research Partnership (UKPRP)

向作者/读者索取更多资源

The study found that higher concentrations of CT-proET-1 and MR-proADM are associated with incident type 2 diabetes, especially in obese individuals. Mendelian randomisation analysis suggests a probable causal link for CT-proET-1.
Background Endothelin-1 (ET-1) and adrenomedullin (ADM) are commonly known as vasoactive peptides that regulate vascular homeostasis. Less recognised is the fact that both peptides could affect glucose metabolism. Here, we investigated whether ET-1 and ADM, measured as C-terminal-proET-1 (CT-proET-1) and mid-regional-proADM (MR-proADM), respectively, were associated with incident type 2 diabetes. Methods Based on the population-based Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium data, we performed a prospective cohort study to examine associations of CT-proET-1 and MR-proADM with incident type 2 diabetes in 12,006 participants. During a median follow-up time of 13.8 years, 862 participants developed type 2 diabetes. The associations were examined in Cox proportional hazard models. Additionally, we performed two-sample Mendelian randomisation analyses using published data. Results CT-proET-1 and MR-proADM were positively associated with incident type 2 diabetes. The multivariable hazard ratios (HRs) [95% confidence intervals (CI)] were 1.10 [1.03; 1.18], P = 0.008 per 1-SD increase of CT-proET-1 and 1.11 [1.02; 1.21], P = 0.016 per 1-SD increase of log MR-proADM, respectively. We observed a stronger association of MR-proADM with incident type 2 diabetes in obese than in non-obese individuals (P-interaction with BMI < 0.001). The HRs [95%CIs] were 1.19 [1.05; 1.34], P = 0.005 and 1.02 [0.90; 1.15], P = 0.741 in obese and non-obese individuals, respectively. Our Mendelian randomisation analyses yielded a significant association of CT-proET-1, but not of MR-proADM with type 2 diabetes risk. Conclusions Higher concentrations of CT-proET-1 and MR-proADM are associated with incident type 2 diabetes, but our Mendelian randomisation analysis suggests a probable causal link for CT-proET-1 only. The association of MR-proADM seems to be modified by body composition.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据